The effect of L-arginine or L-citrulline supplementation on biochemical parameters and the vascular aortic wall in high-fat and high-cholesterol-fed rats

Cell Biochemistry and Function

Volumn 29, Issue 5, 2011, Pages 414-428

  El Kirsh, Amal Ashmawy Ahmed ^a   Abd El Wahab, Hanan Mohamed Fathy ^a   Abd Ellah Sayed, Hala Fahmy ^b  

^a Ain Shams University   (Egypt)

^b Ain Shams University   (Egypt)

Author keywords

Aorta; Hypercholesterolemia; Hyperlipidemia; L arginine; L citrulline; Rat

Indexed keywords

ALANINE AMINOTRANSFERASE; ARGININE; ASPARTATE AMINOTRANSFERASE; CITRULLINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; NITRIC OXIDE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA WALL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BIOCHEMISTRY; BLOOD VESSEL WALL; BODY WEIGHT; CHOLESTEROL DIET; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET SUPPLEMENTATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; THORACIC AORTA; TRANSMISSION ELECTRON MICROSCOPY; UREA BLOOD LEVEL;

ADMINISTRATION, ORAL; ALANINE TRANSAMINASE; ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; AORTA; ARGININE; ASPARTATE AMINOTRANSFERASES; BODY WEIGHT; CHOLESTEROL; CITRULLINE; CREATININE; DIET; DIETARY FATS; ENDOTHELIUM, VASCULAR; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; RATS; TUNICA INTIMA; UREA;

ANIMALIA; RATTUS;

EID: 79960100262     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1766     Document Type: Article

References (78)

1. Turk JR, Henderson K, Vanvickle GD, Watkins J, Laughlin MH. Arterial endothelial function in a porcine model of early stage atherosclerotic vascular disease. Int J Exp Pathol 2005; 86: 335-345.
2. Purohit A, Vyas KB. Hypolipidaemic efficacy of Capparis decidua fruit and shoot extracts in cholesterol fed rabbits. Indian J Exp Biol 2005; 43: 863-866.
3. Buja LM, Kita T, Goldstein JL, Watanabe Y, Brown, MS. Cellular pathology of progressive atherosclerosis in the WHHL rabbit: an animal model of familial hypercholesterolemia. Atherosclerosis 1983; 3: 87-101.
4. Candipan CR, Wang BY, Buitrago R, Tsao PS, Cooke JP. Regression or progression dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol 1996; 16: 44-50.
5. Napoli C, Ackah E, De Nigris F, et al. Chronic treatment with nitric oxide- releasing asprin reduces plasma low- density lipoprotein oxidation-and oxidative stress, arterial oxidation specific epitopes, and atherogenesis in hypercholesterolemic mice. Proc Natl Acad Sci USA 2002; 99: 12467-12470.
6. Hayashi T, Juliet PA, Matsui - Hirai H, et al. L-citrulline and L-arginine supplementation retards the progression of high - cholesterol - diet - induced atherosclerosis in rabbits. Proc Natl Acad Sci USA 2005; 102: 13681-13686.
7. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109(23 suppl 1): III27-III32.
8. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-2551.
9. Ouyyumi AA, Dakak N, Andrews NP, et al. Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atherosclerosis. J Clin Invest 1995; 95: 1747-1755.
10. Stroes E, Kastelein J, Cosentino F, et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 1997; 99: 41-46.
11. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol 2000; 20: 2032-2037.
12. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-arginine improves endothelium - dependent vasodilation in hypercholesterolemic humans. J Clin Invest 1992; 90: 1248-1253.
13. Dubois - Rande JL, Zelinsky R, Roudot F, et al. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine - induced vasoconstriction of human atheromatous coronary arteries. Am J Cardiol 1992; 70: 1269-1275.
14. Napoli C, Williams - Igharro S, De Nigris F, et al. Long - term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc Natl Acad Sci USA 2004; 101: 8797-8802.
15. Boger RH, Bode-Boger SM. The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 2001; 41: 79-99.
16. Loscalzo J. Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism? Arterioscler Thromb Vasc Biol 2003; 23: 3-5.
17. Raghavan SA, Dikshit M. L-citrulline mediated relaxation in the control and lipopolysaccharide - treated aortic rings. Eur J Pharmacol 2001; 431: 61-69.
18. Solomonson LP, Flam BR, Pendleton LC, Goodwin BL, Eichler DC. The caveolar nitric oxide synthase / arginine regeneration system for NO production in endothelial cells. J Exp Biol 2003; 206: 2083-2087.
19. Reeves PG, Nielsen FH, Fahey GC. AIN - 93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN- 76A rodent diet. J Nutr 1993; 123: 1939-1951.
20. Tawfik HE, El-Remessy AB, Matragoon S, Ma G, Caldwell RB, Caldwell RW. Simvastatin improves diabetes induced coronary endothelial dysfunction. J Pharmacol Exp Ther 2006; 319: 386-395.
21. Romero MJ, Platt DH, Tawfik HE, et al. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008; 102: 95-102.
22. Lin-Lee YC, Tanaka Y, Lin CT, Chan L. Effects of an atherogenic diet on apolipoprotein E biosynthesis in the rat. Biochemistry 1981; 20: 6474-6480.
23. Richmond W. Preparation and properties of cholesterol oxidase from Nocardia sp and its application to enzymatic assay of total cholesterol in serum. Clin Chem 1973; 19: 1350-1356.
24. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28: 2077-2080.
25. Lopes - Virella MF, Stone P, Ellis S, Colwell JA. Cholesterol determination in high - density lipoproteins separated by three different methods. Clin Chem 1977; 23: 882-884.
26. Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
27. Wilson PW, Garrison RJ, Castell WP, Feinleib M, Mc-Namara PM, Kannel WB. Prevalence of coronary heart disease in the Framingham offspring study: role of lipoprotein cholesterols. Am J Cardiol 1980; 46: 649-654.
28. Bergmeyer HU, Bowers GN, Horder M, Moss DW. Provisional recommendation on IFCC methods for the measurement of catalytic concentrations of enzymes. Part 2 IFCC methods for aspartate aminotransferase. Clin Chim Acta 1976; 70: F19-F29.
29. Fawcett JK, Scott JE. A rapid and precise method for the determination of urea. J Clin Pathol 1960; 13: 156-159.
30. Larsen K. Creatinine assay by a reaction-kinetic principle. Clin Chim Acta 1972; 41: 209-217.
31. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
32. Rice-Evan C, Miller J. Total antioxidant status in plasma and body fluids. Methods Enzymol 1994; 234: 279-293.
33. Folch BJ, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1957; 226: 497-509.
34. Vogel AJ. A Text Book of Practical Organic Chemistry 3rd edn. English Language Book Society and Longman Group Ltd.: London, 1975; 969-971.
35. Humason GL. Animal Tissue Techniques 4th edn. W.H. Freerman and Company: San Francisco, 1979; Chap 9: 111-131.
36. Lillie RD. Histopathologic Technical and Practical Histochemistry 3rd edn. McGraw-Hill Book Co.: New York, 1965.
37. Weakley BS. A Beginner's Handbook in Biological Transmission Electron Microscopy 2nd edn. Churchill Livingstone: London, 1981; Chap 2: 24-25.
38. Madani S, Lopez S, Blond JP, Prost J, Belleville J. Highly purified soybean protein is not hypocholesterolemic in rats but stimulates cholesterol synthesis and excretion and reduces polyunsaturated fatty acid biosynthesis. J Nutr 1998; 128: 1084-1091.
39. De Nigris F, Lerman A, Ignarro LJ, et al. Oxidation - sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol Med 2003; 9: 351-359.
40. Shahkhalili Y, Finot PA, Hurrell R, Fern E. Effects of food rich in polyphenols on nitrogen excretion in rats. J Nutr 1990; 120: 346-352.
41. Mendez JD, Balderas F. Regulation of hyperglycemia and dyslipidemia by exogenous L-arginine in diabetic rats. Biochimie 2001; 83: 453-458.
42. Yu X, Li YJ, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol-fed rabbits. Life Sci 1994; 54: 753-758.
43. Boger RH, Bode-Boger SM, Mugge A, et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 1995; 117: 273-284.
44. Ignarro LJ, Napoli C. Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis. Curr Atheroscler Rep 2004; 6: 281-287.
45. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Ann Rev Biochem 1994; 63: 175-195.
46. Romero MJ, Platt DH, Caldwell RB, Caldwell RW. Therapeutic use of L-citrulline in cardiovascular disease. Cardiovasc Drug Res 2006; 24: 275-290.
47. Shearer JD, Richards JR, Mills CD, Caldwell MD. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol 1997; 272: E181-E190.
48. Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 1996; 20: 707-727.
49. Abdel-Hamid FF. Hypocholesterolemic effects of portulaca oleracea L. seeds in rats feed a cholesterol rich diet. EJBMB 2008; 26: 273-293.
50. Fukuchi S, Hamaguchi K, Seike M, Himeno K, Sakata T, Yoshimatsu H. Role of fatty acid composition in the development of metabolic disorders in sucrose-induced obese rats. Exp Biol Med 2004; 229: 486-493.
51. Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, Von Eckardstein A. HDL and atherosclerosis: beyond reverse cholesterol transport. Atherosclerosis 2002; 161: 1-16.
52. Luthria DL, Mohammed BS, Sprecher H. Regulation of the biosynthesis of 4, 7, 10, 13, 16, 19-decosahexaenoic acid. J Biol Chem 1996; 271: 16020-16025.
53. Goldfischer S, Schiller B, Wolinsky H. Lipid accumulation in smooth muscle cell lysosomes in primate atherosclerosis. Am J Pathol 1975; 78: 497-504.
54. Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol-fed rabbits: I. Focal increases in arterial LDL concentration precede development of fatty streak lesions. Arteriosclerosis 1989; 9: 895-907.
55. Lee CS, Choi JM, Pak DH, Kang DY, Register TC, Adams MR. Inhibition of expression of P-selectin by antioxidant in cholesterol - fed rats. J Korean Med Sci 1999; 14: 8-14.
56. Nievelstein-Post P, Mottino G, Fogelman A, Frank J. An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit. Arterioscler Thromb 1994; 14: 1151-1161.
57. Humphreys EM. Atherosclerosis in the coronary arteries of rats. J Atheroscler Res 1964; 4: 416-434.
58. Kato K, Elsayed YA, Namoto M, Nakagawa K, Sueishi K. Enhanced expression of tissue factor activity in the atherosclerotic aortas of cholesterol-fed rabbits. Thromb Res 1996; 82: 335-347.
59. Mehta U, Kang BP, Kukreja RS, Bansol MP. Ultrastructural examination of rabbit aortic wall following high fat diet feeding and selenium supplementation: a transmission electron microscopy study. J Appl Toxicol 2002; 22: 405-413.
60. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest 1992; 90: 1168-1172.
61. Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991; 266: 4244-4250.
62. Gaboury J, Woodman RC, Granger DN, Reinhardt P, Kubes P. Nitric oxide prevents leukocyte adherence: role of superoxide. Am J Physiol 1993; 264: 862-867.
63. 2 - reactive species activate primed platelets in human whole blood. Am J Physiol 1993; 264: H1582-H1587.
64. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
65. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 1994; 89: 2176-2182.
66. Quyyumi AA, Dakak N, Diodati JG, Gilligan DM, Panza JA, Cannon RO. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol 1997; 30: 1220-1227.
67. Wang BY, Ho HK, Lin PS, et al. Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation 1999; 99: 1236-1241.
68. Jeremy RW, Mc-Carron H, Sullivan D. Effects of dietary L-arginine on atherosclerosis and endothelium-dependent vasodilatation in the hypercholesterolemic rabbits: response according to treatment duration, anatomic site and sex. Circulation 1996; 94: 498-506.
69. Sarkar R, Webb RC, Stanley JC. Nitric oxide inhibition of endothelial cell mitogenesis and proliferation. Surgery 1995; 118: 274-279.
70. Nishio E, Fukushima K, Shiozaki M, Watanabe Y. Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem Biophys Res Commun 1996; 221: 163-168.
71. Ruiz E, Del Rio M, Somoza B, Ganado P, San ZM, Tejerina T. L-citrulline, the by-product of nitric oxide synthesis, decreases vascular smooth muscle cell proliferation. J Pharmacol Exp Ther 1999; 290: 310-313.
72. Ruiz E, Tejerina T. Relaxant effect of L-citrulline in rabbit vascular smooth muscle. Br J Pharmacol 1998; 125: 186-192.
73. Lassala A, Bazer FW, Cudd TA, et al. Intravenous administration of L-citrulline to pregnant ewes is more effective than L-arginine for increasing arginine availability in the fetus. J Nutr 2009; 139: 660-665.
74. Collins JK, Wu G, Perkins-Veazie P, et al. Watermelon consumption increases plasma arginine concentrations in adults. Nutrition 2007; 23: 261-266.
75. Wu G. Intestinal mucosal amino acid catabolism. J Nutr 1998; 128: 1249-1252.
76. Wu G. Urea synthesis in enterocytes of developing pigs. Biochem J 1995; 312: 717-723.
77. Morris SM. Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr 2002; 22: 87-105.
78. Wu G, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 1-17.